These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8820511)

  • 21. Light-chain removal by plasmapheresis in myeloma-associated renal failure.
    Cserti C; Haspel R; Stowell C; Dzik W
    Transfusion; 2007 Mar; 47(3):511-4. PubMed ID: 17319833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing the treatment of patients with multiple myeloma and renal impairment.
    Grzasko N; Morawska M; Hus M
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):187-98. PubMed ID: 25458082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Approach to acute renal failure with multiple myeloma: role of plasmapheresis.
    El-Achkar TM; Sharfuddin AA; Dominguez J
    Ther Apher Dial; 2005 Oct; 9(5):417-22. PubMed ID: 16202018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interrelationships between blood volume, venous haematocrit and renal failure in myelomatosis.
    Hansen OP; Drivsholm A
    Scand J Haematol; 1978 May; 20(5):461-6. PubMed ID: 96523
    [No Abstract]   [Full Text] [Related]  

  • 25. [Development and treatment of renal insufficiency in multiple myeloma].
    Mølby L; Hansen HH; Jensen EL
    Ugeskr Laeger; 1994 Jul; 156(30):4343-7. PubMed ID: 8066935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis.
    Dimopoulos MA; Roussou M; Gavriatopoulou M; Psimenou E; Eleutherakis-Papaiakovou E; Migkou M; Matsouka C; Mparmparousi D; Gika D; Kafantari E; Ziogas D; Fotiou D; Panagiotidis I; Terpos E; Kastritis E
    Am J Hematol; 2016 May; 91(5):499-502. PubMed ID: 26890495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current approach to diagnosis and management of acute renal failure in myeloma patients.
    Leung N; Behrens J
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):297-302. PubMed ID: 22920640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal insufficiency and failure.
    Dimopoulos MA; Terpos E
    Hematology Am Soc Hematol Educ Program; 2010; 2010():431-6. PubMed ID: 21239831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology.
    Fabbrini P; Finkel K; Gallieni M; Capasso G; Cavo M; Santoro A; Pasquali S
    J Nephrol; 2016 Dec; 29(6):735-746. PubMed ID: 27757797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal failure in multiple myeloma. Pathogenesis and prognostic implications.
    Alexanian R; Barlogie B; Dixon D
    Arch Intern Med; 1990 Aug; 150(8):1693-5. PubMed ID: 2383164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-life experience with plasmapheresis in newly diagnosed multiple myeloma accompanied by acute kidney injury.
    Patir P; Cetin G; Sahin SE; Palak O; Aykas F; Inci A; Karakus V; Kurtoglu E
    Ir J Med Sci; 2024 Apr; 193(2):837-842. PubMed ID: 37768521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of plasmapheresis in immunological kidney diseases. Experience from 1050 completed plasmapheresis treatment sessions].
    Haris A; Arányi J; Braunitzer H; Kálmán E; Merán Z; Soltész M; Polner K
    Orv Hetil; 2011 Jul; 152(28):1110-9. PubMed ID: 21712172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of plasmapheresis in the management of myeloma kidney: a systematic review.
    Gupta D; Bachegowda L; Phadke G; Boren S; Johnson D; Misra M
    Hemodial Int; 2010 Oct; 14(4):355-63. PubMed ID: 20955270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy with or without plasmapheresis in acute renal failure due to multiple myeloma: a meta-analysis.
    Yu X; Gan L; Wang Z; Dong B; Chen X
    Int J Clin Pharmacol Ther; 2015 May; 53(5):391-7. PubMed ID: 25816886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery of renal function after autologous stem cell transplantation in myeloma patients with end-stage renal failure.
    Tauro S; Clark FJ; Duncan N; Lipkin G; Richards N; Mahendra P
    Bone Marrow Transplant; 2002 Oct; 30(7):471-3. PubMed ID: 12368962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of continuous venovenous hemofiltration for acute renal failure due to multiple myeloma cast nephropathy.
    Mehta S; Shtaynberg N; Goldman M; Asti D; Kiroycheva M; Pepe J
    Hematology; 2012 Jul; 17(4):229-31. PubMed ID: 22889516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney.
    Basnayake K; Cheung CK; Sheaff M; Fuggle W; Kamel D; Nakoinz S; Hutchison CA; Cook M; Stoves J; Bradwell AR; Cockwell P
    J Clin Pathol; 2010 Oct; 63(10):884-7. PubMed ID: 20876319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the prognostic significance of renal insufficiency in myeloma. Multivariate analysis].
    López Pascual J; García Ahumada F; Fernández Rañada JM
    Med Clin (Barc); 1987 Nov; 89(16):678-80. PubMed ID: 3695698
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of myeloma kidney: an anti-light-chain approach.
    Misiani R; Tiraboschi G; Mingardi G; Mecca G
    Am J Kidney Dis; 1987 Jul; 10(1):28-33. PubMed ID: 3111253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expert consensus for the diagnosis and treatment of patients with renal impairment of multiple myeloma].
    Renal Impairment of Multiple Myeloma Collaborative Study Group
    Zhonghua Nei Ke Za Zhi; 2017 Nov; 56(11):871-875. PubMed ID: 29136724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.